Home
About Us
Overview
Management Team
Board of Directors
Scientific & Clinical Advisors
Partnerships
The DPX Platform
Overview
Scientific Publications & Posters
Clinical Pipeline
Overview
Maveropepimut-S
DPX-RSV
DPX-COVID-19
Clinical Trials
News & Events
Press Releases
Events
Email Alerts
Annual General and Special Shareholders Meeting
Investors
Overview
Press Releases
Events, Webcasts & Presentations
Financial Info
Stock Data
Filings
Governance
Contact Us
FAQ
Careers
Overview
Life at IMV
Contact
Press Releases
Investors
Investors
Overview
Press Releases
Events, Webcasts & Presentations
Overview
Presentations
Scientific Publications & Posters
Email Alerts
Financial Info
Financial Results
Tax Info
Proxy Info
Stock Option Plan
Deferred Share Unit Plan
Stock Data
NASDAQ: IMV
TSX: IMV
Analyst Coverage
Filings
SEC Filings
SEDAR
Governance
Board of Directors
Board Committees
Governance Documents
Contact Us
FAQ
Year
All Years
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Category
All Releases
Financial Releases
Oct 05, 2009 9:38am EDT
Immunovaccine Inc. Begins Trading on the TSX-V Under the Symbol "IMV"
Prev
1...
28
29
30
31
32
33
34
35
36
37
Email Alerts
Contacts
RSS News Feed
